| | COVID-19 clinical operations
ICON has adopted numerous measures to protect the welfare of patients, to protect the safety of our employees and to ensure the continuity of your research programmes during COVID-19. Learn more about how to keep your trial on track in this evolving environment.
|
Today's Rundown Trump administration allocates $11B for COVID-19 testing as faster tests get approved What's it like to work on J&J's coronavirus vaccine? For one scientist, it's social distancing in the lab, late nights at home Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work HHS details how it is distributing COVID-19 treatment remdesivir Former Sanofi research exec Zerhouni favorite for COVID-19 czar: report FDA greenlights its first coronavirus antigen test for rapid point-of-care screening Biopharma roundup: FDA, CDC and NIAID leaders enter quarantine following exposure; New rapid antigen test authorized Healthcare roundup: Optum sees huge increase in use of telemedicine for behavioral health FDA authorizes saliva-based coronavirus test for at-home use Pfizer plans to farm out manufacturing for some of its drugs to make way for COVID-19 vaccine CommonSpirit came up with a new plan to restart elective procedures. Here's what it says Novartis leans into digital for mid-pandemic lung cancer launch Kaiser Permanente reports $1.1B loss in Q1 China, Iran hackers fingered for targeting COVID-19 vaccine R&D: reports Featured Story | | | Monday, May 11, 2020 The Trump administration will provide $11 billion to states to ramp up testing capabilities to combat the COVID-19 pandemic. |
|
|---|
|
Top Stories Monday, May 11, 2020 Rinke Bos is a scientist. But under the bright spotlight of COVID-19, the Johnson & Johnson immunologist has also become a media spokesperson, online video cast member and one of the many pharma researchers who symbolize hope for the world. Monday, May 11, 2020 After winning a small grant for early vaccine work in March, Novavax just secured the largest-ever investment from CEPI, a global coalition aiding COVID-19 vaccine development. The deal, worth up to $384 million, offers funding not only for clinical work, but manufacturing scale-up if the candidate proves itself. Monday, May 11, 2020 HHS offered details on how it has distributed 1,244 cases of the COVID-19 experimental treatment remdesivir to several states. Monday, May 11, 2020 The U.S. government has narrowed down its list of people to be the face of its COVID-19 drug and vaccine response, and reports suggest Elias Zerhouni is currently the favorite. Saturday, May 9, 2020 The FDA has authorized its first COVID-19 antigen test, bringing a new category of diagnostic against the disease. Monday, May 11, 2020 The FDA authorized its first COVID-19 antigen test, a new category of coronavirus diagnostic similar to the rapid, swab-based tests used for the flu. Meanwhile, White House staffers have tested positive for COVID-19, and FDA, NIAID and CDC leaders are entering quarantine. Monday, May 11, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Friday, May 8, 2020 The FDA authorized its first COVID-19 diagnostic test that allows a person to collect a simple saliva sample themselves without leaving their homes. Monday, May 11, 2020 Pfizer has dedicated enormous resources to gearing up for hundreds of millions of doses of a possible COVID-19 vaccine. But that massive effort requires a trade-off: Pfizer will need to contract out more manufacturing work to keep up supplies of its existing meds. Friday, May 8, 2020 CommonSpirit Health has released a toolkit to its 137 hospitals, including a plan to help assuage patients who may be scared of coming back to the hospital. Monday, May 11, 2020 Before the COVID-19 pandemic, Novartis was already working on digitizing its commercial model. But the outbreak—coupled with a recent OK for targeted lung cancer med Tabrecta—has the company hitting fast forward. Monday, May 11, 2020 Typically, the healthcare group sees its strongest operating margin in the first quarter due to the timing of open enrollment. Monday, May 11, 2020 With drugmakers and government researchers racing after coronavirus drugs and vaccines, law enforcement agencies say hackers are trying to steal some of their discoveries. Now, after news of a potential cyberattack from Iran, the U.S. plans to implicate China in other hacking attempts on companies leading the COVID-19 pack. |
